Search
-
Searchresult: Colorectal cancer risk increases with every year of overweightColorectal cancer risk increases with every year of overweight Press release content type: Press release
Last update: : 18.03.2022
The number of years of life in which a person is overweight is more significant for the risk of colorectal cancer than a single measurement of body weight. This has now been published by scientists…
Press release -
Searchresult: Cancer DNA in the blood: an early warning system for recurrent tumors in childrenCancer DNA in the blood: an early warning system for recurrent tumors in children Press release content type: Press release
Last update: : 16.03.2022
Neuroblastomas release DNA fragments into the blood and cerebrospinal fluid of patients. These genetic material can indicate a possible disease recurrence at an early stage. It also provides…
Press release -
Searchresult: Uǧur Șahin establishes scientific department at HI-TRON MainzUǧur Șahin establishes scientific department at HI-TRON Mainz Press release content type: Press release
Last update: : 15.03.2022
The immunologist, cancer researcher and entrepreneur Uǧur Șahin is establishing a scientific department for mRNA-based cancer immunotherapy at the Helmholtz Institute "HI-TRON Mainz". In HI-TRON…
Press release -
Searchresult: Do gut bacteria influence treatment success of CAR-T cell therapies?Do gut bacteria influence treatment success of CAR-T cell therapies? Press release content type: Press release
Last update: : 14.03.2022
Through the Endeavour Awards, the Mark Foundation supports research projects that bring together scientists from different disciplines to advance the prevention, diagnosis and treatment of cancer.…
Press release -
Searchresult: Identifying Alzheimer's risks - as early as 17 years before diagnosisIdentifying Alzheimer's risks - as early as 17 years before diagnosis Press release content type: Press release
Last update: : 03.03.2022
In order to develop approaches for the prevention and treatment of Alzheimer's dementia in clinical trials, it would be helpful to be able to identify people with a particularly high risk of…
Press release -
Searchresult: New leukemia subgroup identified for the first time solely by altered proteomeNew leukemia subgroup identified for the first time solely by altered proteome Press release content type: Press release
Last update: : 03.03.2022
Researchers have used mass spectrometry to identify for the first time a subgroup of an aggressive blood cancer, acute myeloid leukemia (AML), that can be recognized solely at the level of the…
Press release -
Searchresult: HPV vaccination: Numerous studies provide impressive proof of effectiveness against cervical cancerHPV vaccination: Numerous studies provide impressive proof of effectiveness against cervical cancer Press release content type: Press release
Last update: : 02.03.2022
More and more data from various European countries prove: Vaccination against human papillomavirus not only prevents precancerous lesions, but also reliably protects against cervical cancer. On the…
Press release -
Searchresult: Obesity at a young age - a risk factor for early colorectal cancerObesity at a young age - a risk factor for early colorectal cancer Press release content type: Press release
Last update: : 11.01.2022
The incidence of colorectal cancers in young adults is increasing. At the same time, the proportion of overweight and obese young people is also on the rise. Whether there is a connection between…
Press release -
Searchresult: Algorithm identifies cancer drivers
Last update: : 10.01.2022
Genetic alterations that promote the development and spread of tumors are difficult to identify. This is especially true for mutations in the non-protein-coding regions of the genome, which include…
Press release -
Searchresult: Özlem Türeci appointed new Professor of Personalized Immunotherapy at HI-TRON MainzÖzlem Türeci appointed new Professor of Personalized Immunotherapy at HI-TRON Mainz Press release content type: Press release
Last update: : 07.12.2021
The world-renowned immunologist, cancer researcher, and entrepreneur Özlem Türeci has accepted the professorship of Personalized Immunotherapy at the Mainz University Medical Center and the Helmholtz…
Press release